Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
Sanne Bevers, Sander A.A. Kooijmans, Elien Van de Velde, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 3078-3094
Open Access | Times Cited: 83

Showing 26-50 of 83 citing articles:

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
Shizuko Sei, Aysel Ahadova, Derin B. Keskin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
Tetiana Korzun, Abraham S. Moses, Parham Diba, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1088-1088
Open Access | Times Cited: 15
Lipid Nanoparticle-Based Delivery System─A Competing Place for mRNA Vaccines
Xinyu Zhang, Yuanfang Li, Zehua Zhou
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6219-6234
Open Access | Times Cited: 5
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
High mRNA Expression of 24 Dehydrocholesterol Reductase (DHCR24) in the Treatment of Doxorubicin-Induced Heart Failure in Rats
Rui Zhang, Siyuan Peng, Xuejuan Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 312-312
Open Access
Nonviral targeted mRNA delivery: principles, progresses, and challenges
Xi He, Guohong Li, Li-Hsin Huang, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
The Role of Dendritic Cells in Adaptive Immune Response Induced by OVA/PDDA Nanoparticles
Daniele Rodrigues Pereira, Yunys Pérez-Betancourt, Bianca de Carvalho Lins Fernandes Távora, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 76-76
Open Access
Intralesional injection of CpG ODNs complexed with glatiramer acetate mitigates systemic cytokine toxicities and synergistically advances checkpoint blockade efficacy
Huan Gong, J. Daniel Griffin, Chad E. Groer, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Carrier-Free Nanocombo-Sensitized Photoimmunotherapy via Activation of α2-Adrenergic Receptors
Xiao-Kai Chi, Sihui Wang, Jingjing Gao, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Marginal-zone B cells as promising targets of an mRNA-loaded, lipid-nanoparticle cancer vaccine
Yuichi Suzuki, Mai Yakuwa, Mina Sato, et al.
Next Nanotechnology (2025) Vol. 8, pp. 100154-100154
Open Access
Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
Lidia Gurba-Bryśkiewicz, Wioleta Maruszak, Damian Smuga, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2752-2752
Open Access | Times Cited: 14
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants
Lei Huang, Fanfan Zhao, Muye He, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 479-493
Closed Access | Times Cited: 4
An Ultrahydrating Polymer that Protects Protein Therapeutics and RNA‐Lipid Nanoparticles Against Freezing, Heat and Lyophilization Stress
Anna Herrmann, Srinivas Abbina, Nuthan Vikas Bathula, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 4
Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery
Yue Qin, Adam A. Walters, Nadia Rouatbi, et al.
Biomaterials (2023) Vol. 299, pp. 122158-122158
Open Access | Times Cited: 10
Lipoamino bundle LNPs for efficient mRNA transfection of dendritic cells and macrophages show high spleen selectivity
Franziska Haase, Jana Pöhmerer, Mina Yazdi, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 194, pp. 95-109
Closed Access | Times Cited: 10
The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles
Jessica Anindita, Hiroki Tanaka, Takuma Yamakawa, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 181-181
Open Access | Times Cited: 3
The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
Jingjing Song, Yujun Zhang, Chulin Zhou, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112037-112037
Closed Access | Times Cited: 3
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
Annemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
New insights on extramedullary granulopoiesis and neutrophil heterogeneity in the spleen and its importance in disease
Rongxia Guo, Xuemei Xie, Qian Ren, et al.
Journal of Leukocyte Biology (2024)
Closed Access | Times Cited: 3
Spleen-targeted nanosystems for immunomodulation
Fazhan Wang, Jia Lou, Xiaoke Gao, et al.
Nano Today (2023) Vol. 52, pp. 101943-101943
Closed Access | Times Cited: 9
Lipid-mRNA nanoparticles landscape for cancer therapy
Yin Li, Hengtong Fang, Tao Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 14
Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines
Takayuki Matsumura, Tomohiro Takano, Yoshimasa Takahashi
International Immunology (2022) Vol. 35, Iss. 5, pp. 213-220
Open Access | Times Cited: 14
Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry
Ravi Maharjan, Jae‐Chul Lee, Kyeong Lee, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 53, Iss. 6, pp. 803-826
Closed Access | Times Cited: 8
mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Scroll to top